Results 71 to 80 of about 199,076 (315)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review

The Pan African Medical Journal, 2014
Drug-induced hypersensitivity or Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) is a severe adverse drug-induced reaction. Diagnosing DRESS is challenging due to the diversity of cutaneous eruption and organs involved.
Nissrine EL omairi, Sanae Abourazzak, Sanae Chaouki, Samir Atmani, Moustapha Hida   +4 more
doaj   +1 more source

Commentary: The Fidgety Man with the Skin Rash [PDF]

, 2021
Daniel G. Healy, Soaham Desai, Devangi Desai, Stephen G. Reich   +3 more
openalex   +1 more source

Severe Varicella in adult

The Pan African Medical Journal, 2013
A 35-year-old man presented to the emergency with a 5-day history of fever, chest pain and exanthematous vesicular pruritic rash. His 10-year-old son had been diagnosed with chickenpox 2 weeks earlier. He had no history of chickenpox. On presentation, he
Loubna Benchat, Fatima Zahra Mernissi
doaj   +1 more source

Asymmetrical erythematous rash secondary to subcutaneous emphysema

, 2021
Tahmina Lata, Nicholas Bull, Madeline A. Dick, Benjamin O. Anderson   +3 more
openalex   +2 more sources

Neonatal Rash [PDF]

The Journal of Pediatrics, 2021
Sofia, Varela Branco, Beatriz, Santos Vieira, Catarina, Granjo Morais, Sílvia, Saraiva, Margarida, Pontes   +4 more
openaire   +2 more sources

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

Arthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, Valentin Lacombe, Vincent Jachiet, Michael Zisapel, Iftach Sagy, Oshrat E. Tayer‐Shifman, David Ozeri, Shaye Kivity, Alessandro Tomelleri, Benjamin Terrier, Hagit Peleg, Thibault Comont, Karim Sacre, Pascal Woaye‐Hune, Laurent Arnaud, Estibaliz Lazaro, Vincent Grobost, Francois Lifermann, Maxime Samson, Samuel Ardois, Alice Garnier, Alexandre Maria, Alain Cantagrel, Aurore Meyer, Jean‐David Bouaziz, Mael Heiblig, Lorenzo Dagna, Elisa Diral, Olivier Kosmider, Ori Elkayam, Jérôme Hadjadj, Sophie Georgin‐Lavialle, Olivier Fain, Arsene Mekinian   +35 more
wiley   +1 more source

Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study

Frontiers in Pharmacology
BackgroundFew studies have analysed oxaliplatin-induced adverse events (ADEs) in the immune system and skin and subcutaneous tissues through pharmacovigilance.
Chunhong Zhang, Furong Li, Ying Dai, Yifan Zeng, Xuben Yu, Dawei Shi   +5 more
doaj   +1 more source

Morbilliform rash [PDF]

BMJ, 2004
Furness, C, Sharma, R, Harnden, A
openaire   +3 more sources